...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM - High Level Summary
7
Jan 07, 2016 03:54PM
2
Jan 07, 2016 03:58PM
4
Jan 07, 2016 06:25PM
4
Jan 07, 2016 06:59PM
2
Jan 07, 2016 07:35PM
7
Jan 07, 2016 11:57PM
3
Jan 08, 2016 12:06AM
4
Jan 08, 2016 07:18AM
2
Jan 08, 2016 01:40PM
2
Jan 08, 2016 03:07PM
1
Jan 12, 2016 10:30AM
3
Jan 12, 2016 05:38PM
1
Jan 12, 2016 06:19PM

Jan 12, 2016 06:48PM
5
Jan 12, 2016 08:25PM

fouremm, thanks for the clarification on the shares.

I don't suppose he mentioned how our current share value will be portioned after the split, i.e., what percentage will be held in Zenith Epigenetics Ltd and what percentage in Zenith Capital Corp?

5
Jan 12, 2016 10:14PM
3
Jan 12, 2016 11:04PM
4
Jan 13, 2016 08:58AM
5
Jan 13, 2016 01:37PM
1
Jan 13, 2016 02:01PM
Share
New Message
Please login to post a reply